Redeye: Redeye Initiates Coverage of Lifco
Redeye initiates coverage of Lifco, an increasingly sector-agnostic serial acquirer. Considering the company’s growing operating cash flows, we believe the most critical factors in its investment case are the building of its organisation and scaling up of M&A volume. We see Lifco evolving to accommodate an increasing number of M&A deals and subsidiaries, boding well for its future growth prospects.
Read more and download the Research Report.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/